On-going Commitment to ESG and Access to Medicines

Speaking at the 2023 J.P. Morgan Healthcare Conference, Vas Narasimhan, CEO, speaks with immense pride at Novartis position as an ESG leader, with the example of how in malaria alone, 1.2 billion treatment courses have been delivered to those who need them.
*This video uses audio from the webcasted event.*
J.P. Morgan Healthcare Conference
Event Date: January 08, 2024
Full webcast here: go.novartis.social/49012mq
Full presentation here: go.novartis.social/3SlR2gV
Novartis JPM HC 2024 Coverage: go.novartis.social/49i0IQp
Investor Relations: go.novartis.social/48JEHdf
Investor Events: go.novartis.social/3OnWjD8
Novartis Strategy: go.novartis.social/3uf0cDH
Disclaimer: J.P. Morgan Healthcare Conference live event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: go.novartis.social/3SlR2gV
The J.P. Morgan Healthcare conference live event also contains non-IFRS measures. An explanation of non-IFRS measures can be found on our website go.novartis.social/3Uo61cD.